null
SMILES: Cc1cc2c(c(C)c1C(=O)Nc1ccc(CC(O)=O)cc1)C(C)(C)CCC2(C)C
InChI Key: InChIKey=QWFCVDPZBKASNN-UHFFFAOYSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476228![]() (US10874634, Cmpd No. 10 | US11364220, Compound 10) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 8.23E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476228![]() (US10874634, Cmpd No. 10 | US11364220, Compound 10) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | KEGG PC cid PC sid UniChem | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476228![]() (US10874634, Cmpd No. 10 | US11364220, Compound 10) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | KEGG PC cid PC sid UniChem | n/a | n/a | 8.23E+3 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476228![]() (US10874634, Cmpd No. 10 | US11364220, Compound 10) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) | |||||||||||
More data for this Ligand-Target Pair |